Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) recently released its quarterly financial results for the three months ended March 31, 2025, showing significant developments in revenue and expenditures.
Key Financial Highlights:
Total Revenue: $131.6 million, an increase of approximately 10% from $11...